Literature DB >> 34083218

Being an ADVOCATE for People with ANCA Vasculitis.

Hans-Joachim Anders1, Daigo Nakazawa2.   

Abstract

Entities:  

Keywords:  ANCA; complement; glomerulonephritis; vasculitis

Mesh：

Substances：

Year:  2021        PMID： 34083218      PMCID： PMC8499004          DOI： 10.2215/CJN.03670321

Source DB:  PubMed          Journal:  Clin J Am Soc Nephrol        ISSN： 1555-9041            Impact factor:   10.614


× No keyword cloud information.
  10 in total

1.  Randomized Trial of C5a Receptor Inhibitor Avacopan in ANCA-Associated Vasculitis.

Authors:  David R W Jayne; Annette N Bruchfeld; Lorraine Harper; Matthias Schaier; Michael C Venning; Patrick Hamilton; Volker Burst; Franziska Grundmann; Michel Jadoul; István Szombati; Vladimír Tesař; Mårten Segelmark; Antonia Potarca; Thomas J Schall; Pirow Bekker
Journal:  J Am Soc Nephrol       Date:  2017-04-11       Impact factor: 10.121

Review 2.  ANCA-associated vasculitis: new options beyond steroids and cytotoxic drugs.

Authors:  Umut Selamet; Yuriy B Kovaliv; Caroline O Savage; Lorraine Harper
Journal:  Expert Opin Investig Drugs       Date:  2007-05       Impact factor: 6.206

Review 3.  Complement in ANCA-associated vasculitis: mechanisms and implications for management.

Authors:  Min Chen; David R W Jayne; Ming-Hui Zhao
Journal:  Nat Rev Nephrol       Date:  2017-03-20       Impact factor: 28.314

Review 4.  Extracellular traps in kidney disease.

Authors:  Daigo Nakazawa; Julian A Marschner; Louise Platen; Hans-Joachim Anders
Journal:  Kidney Int       Date:  2018-12       Impact factor: 10.612

Review 5.  Complement alternative pathway in ANCA-associated vasculitis: Two decades from bench to bedside.

Authors:  Benoit Brilland; Anne-Sophie Garnier; Alain Chevailler; Pascale Jeannin; Jean-François Subra; Jean-François Augusto
Journal:  Autoimmun Rev       Date:  2019-11-15       Impact factor: 9.754

6.  Avacopan for the Treatment of ANCA-Associated Vasculitis.

Authors:  David R W Jayne; Peter A Merkel; Thomas J Schall; Pirow Bekker
Journal:  N Engl J Med       Date:  2021-02-18       Impact factor: 91.245

Review 7.  The role of innate immunity in autoimmune tissue injury.

Authors:  Ramanjaneyulu Allam; Hans-Joachim Anders
Journal:  Curr Opin Rheumatol       Date:  2008-09       Impact factor: 5.006

Review 8.  ANCA-associated vasculitis.

Authors:  A Richard Kitching; Hans-Joachim Anders; Neil Basu; Elisabeth Brouwer; Jennifer Gordon; David R Jayne; Joyce Kullman; Paul A Lyons; Peter A Merkel; Caroline O S Savage; Ulrich Specks; Renate Kain
Journal:  Nat Rev Dis Primers       Date:  2020-08-27       Impact factor: 52.329

Review 9.  Hurdles to the introduction of new therapies for immune-mediated kidney diseases.

Authors:  Hans-Joachim Anders; David R W Jayne; Brad H Rovin
Journal:  Nat Rev Nephrol       Date:  2016-01-25       Impact factor: 28.314

Review 10.  Pathogenesis and therapeutic interventions for ANCA-associated vasculitis.

Authors:  Daigo Nakazawa; Sakiko Masuda; Utano Tomaru; Akihiro Ishizu
Journal:  Nat Rev Rheumatol       Date:  2019-02       Impact factor: 20.543
  10 in total
  1 in total

Review 1.  Recent Advancements in the Management of Anti-neutrophil Cytoplasmic Antibody-Associated Vasculitis: A Systematic Review.

Authors:  Hadia Arzoun; Mirra Srinivasan; Santhosh Raja Thangaraj; Siji S Thomas; Alena Yarema; Bridget Lee; Lubna Mohammed
Journal:  Cureus       Date:  2022-02-01
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.